Sky News
@skynews·9.3M subscribers·76.1K videos
Alzheimer's drug that slows decline given green light in UK - but won't be available on NHS
Posted
August 22, 2024
Views
27,919
Likes
156
Comments
322
Engagement
August 22, 2024
27,919
156
322
1.71%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
3:56Now PlayingA drug that can slow the debilitating symptoms of Alzheimer's has been approved by the UK's medicines regulator.
But the NHS watchdog has ruled that the drug lecanemab is not cost-effective and won't be available, meaning it will only be accessible through private healthcare.
In the US the treatment costs £20,000 a year.
#alzheimer #nhs #health
SUBSCRIBE to our YouTube channel for more videos
Follow us on Twitter
Like us on Facebook
Follow us on Instagram
Follow us on TikTok
For more content go to and download our appsApple Android
Sky News Daily podcast is available for free here
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí
To enquire about licensing Sky News content, you can find more information here
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
